System for delivering sequential components
19 claims: 2 independent, 17 dependent
- 1所定の コンポーネントを 所定の 量で 所定の 順序で取り出すためのシステムにおいて、 基部薄膜と、 該基部薄膜に向き合った、該基部薄膜と 部分的に 係合するように押し付けられたフレキシブルなカバー薄膜と、 から形成された一連の連続的な貯蔵ユニットを有しており、 互いに向き合った基部薄膜とカバー薄膜との部分的な係合によって、各貯蔵ユニットの周囲に形成された周縁シールと、各貯蔵ユニットを横切って延びた室シールとが形成されており、これにより、各貯蔵ユニットに、所定のコンポーネントを所定の量で貯蔵するコンポーネント室と、室アクセス領域とが形成されており、前記室シールは、コンポーネント室と室アクセス領域の間に延びており、 基部薄膜とカバー薄膜との部分的な係合によって脆いシール部分と室シールとの間における各室アクセス領域内に破裂可能な室が設けられており、 前記周縁シールは、前記破裂可能な室に圧力を加えて該破裂可能な室を破裂させることによって互いに向き合った基部薄膜とカバー薄膜とを分離させる脆いシール部分と、基部薄膜及びカバー薄膜の少なくともいずれか一方を損傷させない限り分離させることができない破壊的シール部分とを含んでおり、 前記破裂可能な室が破裂すると、破裂した脆いシール部分に沿ってフレキシブルなカバー薄膜によってフレキシブルな剥離フラップが形成され、該剥離フラップが、基部薄膜から剥がし取られ、これによって室シールを解離させ てコンポーネント室を開放し 、これによりコンポーネント室に貯蔵されたコンポーネントの取出しを提供するようになっていることを特徴とする、 所定の コンポーネントを 所定の 量で 所定の 順序で取り出すためのシステム。
- 2前記各貯蔵ユニットが矩形であり、前記 フレキシブルな剥離フラップが各貯蔵ユニットの角隅に位置決めされている、請求項1記載のシステム。
- 3各貯蔵ユニット内の室シールが、コンポーネント室と室アクセス領域との間において、貯蔵ユニットの対角線に沿って延びている、請求項 2 記載のシステム。
- 4基部薄膜もフレキシブルであり、 該基部薄膜は、 フレキシブルなカバー薄膜によって形成された剥離フラップに向き合った剥離フラップを形成する、請求項1記載のシステム。
- 5基部薄膜及びカバー薄膜 が、 一連の連続する貯蔵ユニットの連続的な提供のために、 一列に配置された貯蔵ユニットを提供するように向き合っている、 請求項1記載のシステム。
- 6個別の貯蔵ユニットを提供するために、連続的な貯蔵ユニットの間において、向き合った 基部薄膜及びカバー薄膜 を横断する一連の裂断パーフォレーションが設けられている、請求項5記載のシステム。
- 7前記基部薄膜が前記カバー薄膜の脆いシール部分における縁部を超えて延びていることによって前記基部薄膜が、 貯蔵されたコンポーネントが コンポーネント室から解離された室シールを介して 取り出された時に該コンポーネントを捕捉するためのトレーを提供 して、該トレー上にコンポーネントが保持される 、請求項5記載のシステム。
- 8向き合った 基部薄膜及びカバー薄膜 が取出しスプールに巻き付けられておりかつ内側係止端部と外側末端とを有しており、これによって、前記外側末端から、連続的な貯蔵ユニッ トを 連続的に提供するようになっている、請求項5記載のシステム。
- 9連続的な貯蔵ユニッ トを 連続的に提供する時にデリバリスプールを支持するためのディスペンサが設けられている、請求項8記載のシステム。
- 10連続的な貯蔵ユニットのそれぞれが、先行する貯蔵ユニットと、後続の貯蔵ユニットとに、向き合った薄 膜に 沿っ て固 定されている、請求項1記載のシステム。
- 11カバー薄膜が透明であり、コンポーネントの視覚的認識を可能にしている、請求項1記載のシステム。
- 12カバー薄膜及び基部薄膜が不透明である、請求項1記載のシステム。
- 13各貯蔵ユニットに貯蔵されたコンポーネントに関するデータが、前記各貯蔵ユニットに提供されている、 請求項1記載のシステム。
- 14前記所定の コンポーネントが、 所定の 順序で取り出される、 所定の 用量の 所定の 薬剤である、請求項1記載のシステム。
- 15一連の連続的な貯蔵ユニットが、向き合った薄膜に沿った横列及び縦列のマトリックスである、請求項14記載のシステム。
- 16基部薄膜が、起立するよう に剛 性であり、貯蔵ユニット及び該貯蔵ユニットに連続的に貯蔵された薬剤のマトリックスの起立ディスプレイとして機能する、請求項15記載のシステム。
- 17連続的な貯蔵ユニットの横列及び縦列のマトリックスが 、月 の週に対応する複数の水平方向の列と、各週の7日に対応する7つの垂直方向の列とを有している、請求項15記載のシステム。
- 18薬剤が、シールされた薬剤室内に真空パックされている、請求項14記載のシステム。
- 19薬剤を保存するために、シールされた薬剤室内に不活性ガスが含まれている、請求項14記載のシステム。
Independent claims19
35 paragraphs, as filed
The present application claims the benefit of provisional application serial number 60/790482, filed April 10, 2006.
Technical field The present invention relates to the removal of continuous components, in particular to the removal of components in storage units that are easy to open.
background Traditionally, patients, other tablet takers, and their nurses perform weekly tablet filling operations. They collect storage bottles, bottles and containers of drug stock and fill the receptacle for 7 days. Each container of the receptacle holds all the medication for a day or for a specific period of time. Tablet filling requires the tablet ingestor or nurse to know where the supplied tablets are stored and which drug should be ingested when. For many pill consumers, the print on the drug bottle is too small to read. Caps and sealing devices are difficult to remove. Transferring small tablets to a suitable small container can be a daunting task.
Overview Therefore, it is an object of the present invention to provide a series of continuous storage units for providing small components such as parts or agents to storage units that are easy to open. The burstable chamber in the storage unit is compressed, causing edge rupture, and the detachable flap can be pulled to open the storage unit. Self-assembling products require many assembly steps with many small parts of many dimensions such as bolts, nuts, washers, screws, brackets, small tools and the like. The assembler must arrange and use each part in the specified order for orderly assembly of the product.
Another object of the present invention is to provide such a series of continuous storage units filled with a drug by a qualified person under controlled conditions. Storage units can be automatically filled in major hospitals and mail-order drug warehouses. Orders are filled by trained personnel and skilled technicians using reliable computers and an extensive database.
Another object of the present invention is to provide such a series of continuous storage units for continuously providing the drug for continuous withdrawal. Once each storage unit is provided and the drug is drained, it is intuitively clear which of the remaining storage units is next.
Simply put, these and other objectives of the present invention are achieved by providing a system for retrieving a specified amount of specified components in a specified order. The base thin film and the flexible cover thin film are pressed against face-to-face selective engagement to form a series of continuous storage units. A peripheral seal formed around each storage unit has a brittle seal portion and a destructive seal portion. A sealed drug chamber within each storage unit near the destructive seal stores the dose of drug. The chamber access area within each storage unit is in the vicinity of a brittle seal for access to the drug chamber. A chamber seal formed by the selective engagement of the facing thin films extends across each storage unit between the drug chamber and the chamber access area. The burstable chambers are formed within each chamber access region by the facing thin films during selective engagement. A burstable chamber is provided between the brittle seal portion and the chamber seal. The burstable chamber expands with the applied pressure towards the brittle seal portion of the storage unit. Expansion separates the facing thin films and separates the facing thin films that formed the ruptible chambers until the rupturable chambers cause a peripheral rupture at the brittle seal. When the rupturable chamber ruptures, a flexible release flap is formed by the flexible cover thin film along the ruptured brittle seal. The flap is stripped from the base thin film to dissociate the chamber seal, thereby opening the drug chamber and providing removal of the drug stored in the drug chamber.
A brief description of the drawing Another purpose and advantage of the continuity of the storage unit, as well as the operation of the burstable chamber, will be apparent from the detailed description and drawings below (not shown in actual size).
FIG. 1A is a fragmentary top view of a series of storage units 10X and 10Y and 10Z, showing a drug chamber 16M containing drug 10M.
FIG. 1B is a fragmentary cross-sectional view, generally known at reference lines IB-IB in FIG. 1A, before the rupture of chamber 16B.
FIG. 1C is a fragmentary side view of the storage unit after the rupture of chamber 16B.
FIG. 2 is a fragmentary top view of the take-out sheet 20 of the storage unit 20U.
FIG. 3 is a top view of the take-out strip 30 of the storage unit 30U showing the capture tray 32T.
FIG. 4 is a side view of the drug dispenser 48D for supporting a take-out spool 48 containing a roll of continuous storage unit 40.
FIG. 5 is a front view of the calendar-type drug retrieval system 50 having a rigid base 52B.
The first number of each reference code in the figure above indicates the drawing in which the element or feature is most prominently shown. The second number indicates the associated element or feature, and the last letter (if used) indicates the component of the element or feature.
Reference code in the drawing The table below lists the reference codes used in the drawings and recognizes the elements indicated by each code. 10 Extraction system 10K corner 10M drug 10X continuous storage unit 10Y continuous storage unit 10Z continuous storage unit 10XY boundary 10YZ boundary 12B base thin film 12C cover thin film 12P peripheral rupture 14B Base Flexible Peel Flap 14C cover flexible peel flap 14D Destructive seal part (left side and right side) 14F Fragile seal part (left side and right side) 14S Diagonal chamber seal 14XY tear wire 14YZ tear wire 16B burstable room 16M sealed drug room 16R room access area 20 Take-out sheet 20K corner 20U continuous storage unit 24P Rupture Perforations 24P 26R room access area 30 Take-out strip 30L medical data label 30U continuous storage unit 32B base thin film 32C cover thin film 32T capture tray 34F Fragile seal part 36M drug room 36R room access area 40M drug 40U continuous storage unit 48 Take-out spool 48D drug dispenser 48M inner locking end 48T outer end 50 calendar matrix 50A morning storage unit 50B afternoon storage unit 50U storage unit 52B Rigid base thin film
Normal Embodiment (Fig. 1A, B) System 10 supplies a specified amount of a specified component, such as a specified dose of drug 10M, in a specified order (see Figure 1A). The flexible cover thin film 12C is pressed to selectively engage the base thin film 12B (see Figure 1B). The selective engagement of the facing thin films forms a series of continuous storage units 10X and 10Y and 10Z. A peripheral seal is formed around each storage unit by the pressed selective engagement. The peripheral seal has a brittle seal portion and a destructive seal portion. The peripheral seal for the storage unit 10Y has a brittle seal portion 14F (no hatching) and a destructive seal portion 14D (double hatching). The brittle seal formed by the two heat-pressed thin films can be separated by simply pulling the thin films apart without causing harmful damage to each thin film. However, the destructive seal cannot be separated without damage to one or both of the thin films.
A sealed drug chamber 16M for storing drug doses is located near the destructive seal within each storage unit. A chamber access area 16R for access to the drug chamber is adjacent to a brittle seal within each storage unit. A diagonal chamber seal 14S formed by the pressed selective engagement of facing thin films extends across each storage unit between the drug chamber and the chamber access area. A burstable chamber 16B is positioned within each chamber access area between the brittle seal portion and the chamber seal. The burstable chamber is formed by a volumetric gas such as ambient air trapped between the thin films facing each other during selective engagement. The burstable chamber expands towards the brittle seal of the storage unit under applied pressure (see Figures 1A and 1B). The swelling separates the facing thin films that form the rupture chamber until the rupture chamber produces a peripheral rupture 12P (see Figure 1C) at the brittle seal. A flexible cover thin film forms a flexible peel flap 14C along the ruptured brittle seal as the rupturable chamber ruptures. The flap is stripped from the base thin film by the user to separate the chamber seal to open the pharmacy and provide access to the drug stored in the pharmacy. The user can be a patient in need of the drug, or a nurse or other healthcare professional who administers the drug.
Destructive seals are stronger than brittle seals due to higher temperatures and / or pressures and / or rest times during the pressing phase of seal formation. That is, the destructive seal is more fused than the brittle seal. Preferably, the chamber seal is larger than the weak brittle seal but not as strong as the strong destructive seal. The chamber seal is stronger than the weak brittle seal so that the chamber seal does not separate between the ruptures of the rupturable chamber that causes the peripheral rupture. The chamber seal is weaker than the strong destructive seal so that the drug chamber can be opened after the rupture of the brittle seal.
U.S. Pat. No. 6,726,364, issued to the inventor on April 27, 2004, points to a rupture chamber that provides flank flaps facing along the starring rupture. The flaps are pulled by the user to open the room and provide the product. The subject matter of US Pat. No. 6,726,364 is incorporated herein by reference in its entirety.
Diagonal chamber seal (Fig. 1A) A chamber seal within each storage unit extends diagonally across the storage unit between the drug chamber and the chamber access area. The diagonal chamber seal 14S (see Figure 1A) forms a triangle for the drug chamber 16M and the chamber access area 16R. The triangular drug chamber has a destructive seal 14D (left and right) along the two sides and a diagonal chamber seal 14S along the hypotenuse. The triangular chamber access area has a brittle seal 14F (left and right) along the two sides and a chamber seal 14S along the hypotenuse. The chamber seal is about 1.4 times as long as one side of the brittle seal. When the chamber seal is separated, the user has maximum finger or hand access to the drug in the drug chamber. Other off-diagonal configurations can be used. FIG. 2 shows an asymmetrical embodiment in which the room access region 26R is limited to a small region at the corner 20K. FIG. 3 shows a linear embodiment, in which the drug chamber 36M is larger than the chamber access area 36R.
The boundary between successive storage units has a destructive seal and a brittle seal. The boundary 10XY between units 10X and 10Y has a brittle seal 14F (right side) of unit 10X adjacent to the destructive seal 14D (left side) of unit 10Y. Similarly, the boundary 10YZ between units 10Y and 10Z has a brittle seal 14F (right side) of unit 10Y adjacent to the destructive seal 14D (left side) of unit 10Z. The brittle seal is stripped off when the storage unit is opened, leaving the adjacent destructive seal intact to maintain the integrity of the adjacent storage unit. The cover thin film 12C has a tear line 14XY along the boundary 10XY and a tear line 14YZ along the boundary 10YZ. The tear line is located between the brittle seal and the destructive seal so that the cover thin film of one storage unit can be pulled away from the cover thin film of the adjacent storage unit. This tear line is preferably a depth-controlled laser cutting through the cover thin film, which ends in the base thin film.
The withdrawal system can have a flexible cover thin film with a rigid base thin film, which provides one flexible release flap. The user holds the rigid base and pulls the flexible flap apart to expose the drug. Alternatively, the base thin film can also be flexible, forming a flexible release flap 14B facing the release flap 14C (see FIG. 1C) formed by the flexible cover thin film 12C. A pair of peel flaps facilitates the release of the chamber seal.
The peel flaps can be positioned at the corners of each storage unit. The corner 10K makes it easy for the user to grab the peel flap (see Figure 1C) and peel the unsealed brittle seal 14F (left and right). Alternatively, the peel flap can be positioned midway between the two corners (see Figure 3).
Strip embodiment (Fig. 3) The base and cover thin films are strips for the continuous continuous provision of continuous storage units in a strip array. The base thin film strip 32B (see FIG. 3) is wider than the cover thin film strip 32C and extends beyond the brittle peripheral seal portion 34F of the cover thin film. This extension provides a tray 32T for capturing the stored drug as it is removed. The capture tray has a protruding step for holding the drug on the tray.
Facing thin film strips are wrapped around a take-out spool 48 (FIG. 4) with an inner locking end 48M and an outer end 48T for continuous provision of strips of storage units that are continuous from the ends. .. A drug dispenser 48D can be provided to support the withdrawal spool and storage unit. The drug 40M is vacuum packed in a sealed drug chamber provided on the strip of the storage unit. Removing air from the drug chamber reduces transport volume and spool size requirements. Even the slightest vacuum locks the drug in place during transport and handling, preventing the drug from rubbing against each other. Alternatively, an inert gas can be provided in the sealed drug chamber to store the drug. A nitrogen flush introduced just before sealing the drug chamber eliminates ambient oxygen.
The cover thin film can be transparent, allowing visual recognition of the drug. Drugs are often known to users or nurses only by color or size or shape. The thin film is color coded to indicate the due date for taking the drug. For example, pink indicates morning, yellow indicates noon, and blue indicates evening. Alternatively, the cover and base films can be opaque to avoid UV and other light damage.
Row and column embodiments (FIGS. 2 and 5) A series of contiguous storage units can be a matrix of rows and columns across sheets of facing thin films. You can see the total inventory of drugs at a glance. A series of fissure perforations 24P (see Figure 2) traverses the matrix between adjacent storage units 20U , allowing the provision of one storage unit. The drug storage unit is torn from the matrix and distributed individually. Alternatively, each of the contiguous storage units can be firmly anchored to the previous and subsequent storage units along a strip of thin film facing each other (see Figure 3). The empty storage unit remains on the strip after removal, along with a complete storage unit containing the forgotten drug, as a record of obedience.
The calendar matrix 50 of the contiguous storage unit 50U has multiple horizontal columns corresponding to the week of a particular month. The matrix also has seven vertical columns corresponding to the seven days of each week. The user can easily place and recognize the drug for each day. The calendar can be divided into morning and afternoon storage units 50A and 50B as shown for Tuesday 4th in Figure 5. The base thin film for the calendar matrix can be self-supporting and rigid enough to function as an upright display of the matrix of the storage unit and the drug continuously stored in the storage unit.
Medical data Medical data on the drug can be associated with each storage unit. The name and dose of the drug can be listed along with the schedule (date and time of day for ingestion). Significant side effects and emergency numbers can be listed. The name and age of the patient and the name of the doctor or nurse may be provided. The medical data can be printed directly on the thin film or directly on the label 30L (FIG. 3) later fixed to the thin film, or inserted into the drug chamber or chamber access area. Basic information can be included in a quick scan format such as a barcode. A wider range of data, such as medical history, can be included in a suitable mega format, such as tuned digital data.
Industrial use It will be apparent to those skilled in the art that the object of the present invention has been achieved as previously described. Various changes can be made in the structures and embodiments presented herein without departing from the concept of the invention. In addition, the features of the embodiments shown in the various drawings can be used in combination with the embodiments shown in the other drawings. Therefore, the scope of the invention should be determined by the following claims and their legal equivalents.
<figref num="1A">It is a fragmentary top view of a series of storage units 10X and 10Y and 10Z, showing a drug chamber 16M containing drug 10M.</figref><figref num="1B">It is a fragmentary cross-sectional view generally known at reference line IB-IB in FIG. 1A before the rupture of chamber 16B.</figref><figref num="1C">It is a fragmentary side view of the storage unit after the rupture of chamber 16B.</figref><figref num="2">It is a fragmentary top view of the take-out sheet 20 of the storage unit 20U.</figref><figref num="3">It is a top view of the take-out strip 30 of the storage unit 30U which shows the capture tray 32T.</figref><figref num="4">FIG. 5 is a side view of a drug dispenser 48D for indicating a take-out spool 48 containing a roll of continuous storage unit 40.</figref><figref num="5">It is a front view of the calendar type drug withdrawal system 50 which has a rigid base 52B.</figref>
Code description
10 Extraction System, 10K Corner, 10M Drug, 10X Continuous Storage Unit, 10Y Continuous Storage Unit, 10Z Continuous Storage Unit, 10XY Boundary, 10YZ Boundary, 12B Base Thin Film, 12C Cover Thin Film, 12P Peripheral Rupture, 14B Base Flexible Peel Flap, 14C Cover Flexible Peel Flap, 14D Destructive Seal Part (Left and Right), 14F Fragile Seal Part (Left and Right), 14S Diagonal Chamber Seal, 14XY Rupture, 14YZ Rupture, 16B Ruptable Room, 16M sealed drug room, 16R room access area, 20 extraction sheet, 20K corner, 20U continuous storage unit, 24P tear perforation 24P, 26R room access area, 30 extraction strip, 30L medical data label, 30U continuous storage unit, 32B base thin film, 32C cover thin film, 32T capture tray, 34F Fragile Sealed Area, 36M Drug Room, 36R Room Access Area, 40M Drug, 40U Continuous Storage Unit, 48 Ejection Spool, 48D Drug Dispenser, 48M Inner Locking End, 48T Outer End, 50 Calendar Matrix, 50A Morning Storage Unit , 50B afternoon storage unit, 50U storage unit, 52B rigid base thin film
2 sheets
Sheet 1 Sheet 2
Every citation, both ways
| Document | Relation | Office |
|---|---|---|
| JP2000007028A | Cites | Japan |
| JP2006500289A | Cites | Japan |
| JP2002248156A | Cites | Japan |
| WO2005009326A1 | Cites | World Intellectual Property Organization (WIPO) |
| JP2005132491A | Cites | Japan |
| JP2007531541A | Cites | Japan |
21 members in 12 offices
Priority claims14
| Document | Office | Kind | Date |
|---|---|---|---|
| 60790482 | United States of America | – | |
| 79048206 | United States of America | P | |
| 79048206 | United States of America | P | |
| 11724516 | United States of America | – | |
| 72451607 | United States of America | A | |
| 72451607 | United States of America | A | |
| 2007053477 | European Patent Office (EPO) | W | |
| 2007053477 | European Patent Office (EPO) | W | |
| 2006790482 | – | – | – |
| 2007724516 | – | – | – |
| 2007053477 | – | – | – |
| US20060790482P | – | – | – |
| US20070724516 | – | – | – |
| WO2007EP53477 | – | – | – |
Members21
| Document | Office | Kind | |
|---|---|---|---|
| US2007235369A1 | United States of America | A1 | |
| AU2007235938A1 | Australia | A1 | |
| CA2648868A1 | Canada | A1 | |
| WO2007116067A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP2007647A1 | European Patent Office (EPO) | A1 | |
| MX2008012957A | Mexico | A | |
| KR20090033834A | Republic of Korea | A | |
| CN101448715A | China | A | |
| JP2009539419A | Japan | A | |
| RU2008143910A | Russian Federation | A | |
| US7909165B2 | United States of America | B2 | |
| CN101448715B | China | B | |
| EP2007647B1 | European Patent Office (EPO) | B1 | |
| AT517820T | Austria | T | |
| ATE517820T1 | Austria | T1 | |
| BRPI0711531A2 | Brazil | A2 | |
| JP5114472B2This record | Japan | B2 | |
| RU2472685C2 | Russian Federation | C2 | |
| AU2007235938B2 | Australia | B2 | |
| KR101369778B1 | Republic of Korea | B1 | |
| CA2648868C | Canada | C |
27 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Cancellation because of no payment of annual feesLAPS | LAPS | |
| Receipt of annual feesJAPANESE INTERMEDIATE CODE: R250R250 | R250 | |
| Receipt of annual feesJAPANESE INTERMEDIATE CODE: R250R250 | R250 | |
| Receipt of annual feesJAPANESE INTERMEDIATE CODE: R250R250 | R250 | |
| Receipt of annual feesJAPANESE INTERMEDIATE CODE: R250R250 | R250 | |
| Receipt of annual feesJAPANESE INTERMEDIATE CODE: R250R250 | R250 | |
| Receipt of annual feesJAPANESE INTERMEDIATE CODE: R250R250 | R250 | |
| Receipt of annual feesJAPANESE INTERMEDIATE CODE: R250R250 | R250 | |
| Renewal fee payment (event date is renewal date of database)FPAY | FPAY | |
| Certificate of patent or registration of utility modelJAPANESE INTERMEDIATE CODE: R150R150 | R150 | |
| Certificate of patent or registration of utility modelJAPANESE INTERMEDIATE CODE: R150R150 | R150 | |
| First payment of annual fees (during grant procedure)JAPANESE INTERMEDIATE CODE: A61A61 | A61 | |
| Written decision to grant a patent or to grant a registration (utility model)JAPANESE INTERMEDIATE CODE: A01A01 | A01 | |
| Written decision to grant a patent or to grant a registration (utility model)JAPANESE INTERMEDIATE CODE: A01A01 | A01 | |
| Decision of grant or rejection writtenTRDD | TRDD | |
| Request for written amendment filedJAPANESE INTERMEDIATE CODE: A523A521 | A521 | |
| Written permission of extension of timeJAPANESE INTERMEDIATE CODE: A602A602 | A602 | |
| Written request for extension of timeJAPANESE INTERMEDIATE CODE: A601A601 | A601 | |
| Written permission of extension of timeJAPANESE INTERMEDIATE CODE: A602A602 | A602 | |
| Written request for extension of timeJAPANESE INTERMEDIATE CODE: A601A601 | A601 | |
| Written permission of extension of timeJAPANESE INTERMEDIATE CODE: A602A602 | A602 | |
| Written request for extension of timeJAPANESE INTERMEDIATE CODE: A601A601 | A601 | |
| Notification of reasons for refusalJAPANESE INTERMEDIATE CODE: A131A131 | A131 | |
| Report on retrievalJAPANESE INTERMEDIATE CODE: A971007A977 | A977 | |
| Notification of resignation of power of attorneyJAPANESE INTERMEDIATE CODE: A7424RD04 | RD04 | |
| Notification of resignation of power of attorneyJAPANESE INTERMEDIATE CODE: A7424RD04 | RD04 | |
| Written request for application examinationJAPANESE INTERMEDIATE CODE: A621A621 | A621 |
Numbers
- Publication
- 5114472
- Publication, DOCDB
- 5114472
- Publication, EPODOC
- JP5114472B
- Application
- 2009504726
- Application, DOCDB
- 2009504726
- Application, EPODOC
- JP20090504726
Titles2
- Japanese
- 連続的なコンポーネントを取り出すためのシステム
- English
- System for retrieving continuous components
Classification
- CPC, 7
- B65D75/5855
- B65D75/34
- B65D75/323
- B65D2207/00
- B65D2575/3245
- B65D75/32
- B65D75/58
- IPC, 4
- A61J1 03
- A61J7 04
- B65D75 30
- B65D75 60
